178 related articles for article (PubMed ID: 25222053)
1. The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay.
Brandow AM; Farley RA; Dasgupta M; Hoffmann RG; Panepinto JA
J Pediatr Hematol Oncol; 2015 Jan; 37(1):10-5. PubMed ID: 25222053
[TBL] [Abstract][Full Text] [Related]
2. Neuropathic pain in patients with sickle cell disease.
Brandow AM; Farley RA; Panepinto JA
Pediatr Blood Cancer; 2014 Mar; 61(3):512-7. PubMed ID: 24167104
[TBL] [Abstract][Full Text] [Related]
3. Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease.
Ellison AM; Bauchner H
J Natl Med Assoc; 2007 Mar; 99(3):192-6. PubMed ID: 17393942
[TBL] [Abstract][Full Text] [Related]
4. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
[TBL] [Abstract][Full Text] [Related]
5. Admission and length of stay due to painful vasoocclusive crisis in children.
Rogovik AL; Li Y; Kirby MA; Friedman JN; Goldman RD
Am J Emerg Med; 2009 Sep; 27(7):797-801. PubMed ID: 19683107
[TBL] [Abstract][Full Text] [Related]
6. Neuropathic pain in individuals with sickle cell disease.
Sharma D; Brandow AM
Neurosci Lett; 2020 Jan; 714():134445. PubMed ID: 31454562
[TBL] [Abstract][Full Text] [Related]
7. Children with sickle cell disease and human immunodeficiency virus-1 infection: use of inpatient care services in the United States.
Kourtis AP; Bansil P; Johnson C; Meikle SF; Posner SF; Jamieson DJ
Pediatr Infect Dis J; 2007 May; 26(5):406-10. PubMed ID: 17468650
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Geographic Characterization of 30-Day Readmissions in Pediatric Sickle Cell Crisis Patients.
McMillan JE; Meier ER; Winer JC; Coco M; Daymont M; Long S; Jacobs BR
Hosp Pediatr; 2015 Aug; 5(8):423-31. PubMed ID: 26231632
[TBL] [Abstract][Full Text] [Related]
9. Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events.
Brandow AM; Brousseau DC; Panepinto JA
Br J Haematol; 2009 Mar; 144(5):782-8. PubMed ID: 19055663
[TBL] [Abstract][Full Text] [Related]
10. Urgency of emergency department visits by children with sickle cell disease: a comparison of 3 chronic conditions.
Bundy DG; Strouse JJ; Casella JF; Miller MR
Acad Pediatr; 2011; 11(4):333-41. PubMed ID: 21764017
[TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.
Pizzo E; Laverty AA; Phekoo KJ; AlJuburi G; Green SA; Bell D; Majeed A
J Public Health (Oxf); 2015 Sep; 37(3):529-39. PubMed ID: 24796312
[TBL] [Abstract][Full Text] [Related]
12. Variation in hospitalizations and hospital length of stay in children with vaso-occlusive crises in sickle cell disease.
Panepinto JA; Brousseau DC; Hillery CA; Scott JP
Pediatr Blood Cancer; 2005 Feb; 44(2):182-6. PubMed ID: 15390359
[TBL] [Abstract][Full Text] [Related]
13. Interventions for treating neuropathic pain in people with sickle cell disease.
Asnani MR; Francis DK; Brandow AM; Hammond Gabbadon CE; Ali A
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012943. PubMed ID: 31273755
[TBL] [Abstract][Full Text] [Related]
14. Inpatient use of laxatives during opioid administration in children with sickle cell disease.
O'Brien SH; Fan L; Kelleher KJ
Pediatr Blood Cancer; 2010 Apr; 54(4):559-62. PubMed ID: 20049931
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease.
Wilkie DJ; Molokie R; Boyd-Seal D; Suarez ML; Kim YO; Zong S; Wittert H; Zhao Z; Saunthararajah Y; Wang ZJ
J Natl Med Assoc; 2010 Jan; 102(1):18-27. PubMed ID: 20158132
[TBL] [Abstract][Full Text] [Related]
16. Time trends, sociodemographic and health factors associated with discharge and length of stay of hospitalised patients with sickle cell disease in Ghana: a retrospective analysis of national routine health database.
Narh CT; Der J; Ofosu A; Blettner M; Wollschlaeger D
BMJ Open; 2021 Oct; 11(10):e048407. PubMed ID: 34610933
[TBL] [Abstract][Full Text] [Related]
17. Screening for neuropathic pain in patients with sickle cell disease: is a single assessment scale sufficient?
Antunes FD; Silva Junior CL; Cerqueira KS; do Livramento Faro M; Cipolotti R
Orphanet J Rare Dis; 2019 May; 14(1):108. PubMed ID: 31088489
[TBL] [Abstract][Full Text] [Related]
18. Association between Hospital Volume and Within-Hospital Intensive Care Unit Transfer for Sickle Cell Disease in Children's Hospitals.
Raphael JL; Richardson T; Hall M; Oyeku SO; Bundy DG; Kalpatthi RV; Shah SS; Ellison AM
J Pediatr; 2015 Dec; 167(6):1306-13. PubMed ID: 26470686
[TBL] [Abstract][Full Text] [Related]
19. Impact of environmental tobacco smoke on children with sickle cell disease.
West DC; Romano PS; Azari R; Rudominer A; Holman M; Sandhu S
Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1197-201. PubMed ID: 14662575
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants in the treatment of neuropathic pain.
Sindrup SH; Otto M; Finnerup NB; Jensen TS
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):399-409. PubMed ID: 15910402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
